跳至主要内容
临床试验/JPRN-UMIN000048070
JPRN-UMIN000048070尚未招募1 期

Efficacy and safety of Janus kinase 1 inhibitor for chronic pouchitis in patients with ulcerative colitis - Efficacy of Janus kinase 1 inhibitor for pouchitis

Hyogo medical university Department of Gastroenterological Surgery0 个研究点目标入组 50 人开始时间: 2022年7月1日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who dose not agree the treatment with filgochinib.

研究者

发起方
Hyogo medical university Department of Gastroenterological Surgery

相似试验

暂停
不适用
Efficacy and safety of selective JAK 1 inhibitor Filgotinib in active rheumatoid arthritis patients with inadequate response to conventional synthetic disease-modifying antirheumatic drugs: Comparative study with Filgotinib and interleukin 6 inhibitor examined by clinical index as well as musculoskeletal ultrasound assessment(TRANSFORM study): Study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trialRheumatoid arthritis
JPRN-jRCTs071200107Kawakami Atsushi400
Unknown
3 期
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateRheumatoid ArthritisJAK InhibitorIL-6 InhibitorMusculoskeletal UltrasoundBiomarker
NCT05090410Atsushi Kawakami400
招募中
2 期
Efficacy of NK1 receptor antagonist (aprepitant) in the cancer chemotherapies for hematologic malignancies.hematologic malignancies
JPRN-UMIN000006690Kagoshima University Hospital, division of Hematology and Immunology40
进行中(未招募)
不适用
A Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) - COMFORT IIMedDRA version: 12.0Level: LLTClassification code 10028537Term: MyelofibrosisMyelofibrosis
EUCTR2009-009858-24-ITIncyte Corporation150
进行中(未招募)
1 期
Anakinra as prevention of mucositis and fever in patients with a stem cell transplantatioMucositis and febrile neutropeniaMedDRA version: 19.0Level: LLTClassification code 10028127Term: MucositisSystem Organ Class: 100000004867MedDRA version: 19.0Level: PTClassification code 10016288Term: Febrile neutropeniaSystem Organ Class: 10005329 - Blood and lymphatic system disorders
EUCTR2016-004419-11-NLRadboud university medical center18